Cargando…
Development of a proteomic platform for EBV and KSHV serological screening
Autores principales: | Wang, Leyao, Zheng, Dasheng, Zhu, Jian, Liao, Gangling, Woodard, Crystal, Chiou, C-J, Hayward, Gary, Desai, Prashant, Ambinder, Richard, Zhu, Heng, Hayward, S Diane |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002675/ http://dx.doi.org/10.1186/1750-9378-5-S1-A18 |
Ejemplares similares
-
Comparison of Humoral Immune Responses to Epstein-Barr Virus and Kaposi’s Sarcoma–Associated Herpesvirus Using a Viral Proteome Microarray
por: Zheng, Dasheng, et al.
Publicado: (2011) -
KSHV regulation of fibulins in Kaposi’s sarcoma: implications for tumorigenesis
por: Alcendor, Donald, et al.
Publicado: (2010) -
C/EBPbeta mediates bortezomib-induced EBV and KSHV lytic gene expression
por: O’Farrell, Courtney, et al.
Publicado: (2010) -
Phosphorylation of the Chromatin Binding Domain of KSHV LANA
por: Woodard, Crystal, et al.
Publicado: (2012) -
The Prevalence of EBV and KSHV in Odontogenic Lesions
por: Alsaegh, Mohammed Amjed, et al.
Publicado: (2022)